METALLOPROTEASES AND INHIBITORS EXPRESSION IN MYOCARDIUM UNDER ISCHEMIC CONDITIONS AFTER ALLOGENIC BIOMATERIAL INTRODUCTION

METALLOPROTEASES AND INHIBITORS EXPRESSION IN MYOCARDIUM UNDER ISCHEMIC CONDITIONS AFTER ALLOGENIC BIOMATERIAL INTRODUCTION

Aim. To assess the expression of ММР-9 and TIMP-2 after intramyocardial injection of the allogenic biomaterial (AB) into ischemized myocardium in rodents.Material and methods. One hundred Wistar rodents were used, who underwent ligation of coronary artery. The experiment group (n=50), together with...

Full description

Bibliographic Details
Main Authors:	A. I. Lebedeva, S. A. Muslimov, E. M. Gareev, S. V. Popov, S. A. Afanasyev, D. S. Кondratyeva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-08-01
Series:	Российский кардиологический журнал
Subjects:	biomaterial alloplant myocardial infarction ммр-9 timp-2
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2844

Similar Items

Stimulation of autologous progenitorial and committed cells in ischemically damaged myocardium
by: A. I. Lebedeva, et al.
Published: (2018-12-01)

FUNCTIONAL STATE OF MYOCARDIUM AFTER APPLICATION OF A NON-CELLULAR ALLOGENIC MATERIAL FOR STIMULATION OF REGENERATION CAPACITY IN EXPERIMENTAL INFARCTION
by: S. A. Afanasiev, et al.
Published: (2018-04-01)

IMMUNOLOGICAL CHARACTERISTICS OF PATIENTS WITH DIFFERENT CORNEAL DISORDERS TREATED BY LAMELLAR KERATOPLASTY BY MEANS OF A LLOPLANT BIOMATERIAL
by: R. Z. Kadyrov, et al.
Published: (2014-07-01)

Correction of cicatricial changes in subacute stage of myocardial infarction with using of dispersed allogenic biomaterial
by: A. I. Lebedeva, et al.
Published: (2019-08-01)

Predictive value of MMP-2, MMP-9, TIMP-1 in surgical treatment of localized renal cell cancer
by: A. I. Tarasenko, et al.
Published: (2021-06-01)

Allogeneic biomaterial: a fibrosis inhibitor in ischemic myocardial damage
by: A. I. Lebedeva, et al.
Published: (2023-04-01)

Macrophages as homeostatic regulators in the ischemically damaged myocardium after use of allogenic biomaterial
by: A. I. Lebedeva, et al.
Published: (2020-04-01)

THE VALUES OF MATRIX METALLOPROTEASE-9 AND TISSUE METALLOPROTEASE INHIBITOR-1 IN ACUTE MYOCARDIAL INFARCTION WITH ANEURYSM FORMATION
by: A. V. Govorin, et al.
Published: (2014-07-01)

CLINICAL PREDICTIVE VALUE OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IMYOCARDIAL REMODELING DEVELOPMENT IN PATIENTS HAVING Q-WAVE MYOCARDIAL INFARCTION
by: A. S. Vorobyev, et al.
Published: (2019-06-01)

Effect of intramyocardial allogenic biomaterial injection on angiogenesis and postischemic scar remodeling in rats
by: A. I. Lebedeva, et al.
Published: (2020-10-01)

Changes of exosomal matrix metalloproteinases level in colorectal cancer associated with sex and metabolic disturbance
by: N. V. Yunusova, et al.
Published: (2019-11-01)

Impact of Biomaterials on Differentiation and Reprogramming Approaches for the Generation of Functional Cardiomyocytes
by: Camilla Paoletti, et al.
Published: (2018-08-01)

Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction
by: Vineeta Sharma, et al.
Published: (2021-09-01)

Matrix metalloprotease 9 and remodeling after myocardial infarction
by: M. G. Shurygin, et al.
Published: (2013-04-01)

THE USE OF DIFFERENT DONOR MATERIALS IN KERATOPLASTY (LITERATURE REVIEW)
by: A. V. Kirillichev, et al.
Published: (2015-12-01)

The use of different donor materials in keratoplasty (literature review)
by: A.V. Kirillichev, et al.
Published: (2013-01-01)

SURGICAL AND ENDOVASCULAR REVASCULARIZATION OF MYOCARDIUM IN MULTIVESSEL DISEASE
by: I. G. Gordeev, et al.
Published: (2016-02-01)

Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study
by: Ebru Alp, et al.
Published: (2017-02-01)

Successful Surgical Treatment of Postinfarction Rupture of Left Ventricular Myocardium
by: M. K. Mazanov, et al.
Published: (2020-10-01)

Prevention of post-infarction cardiac remodeling after using the non-cellular biomaterial in the experiment
by: S. A. Afanasiev, et al.
Published: (2019-08-01)

Protective Effects of Circulating TIMP3 on Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study
by: Heng Chen, et al.
Published: (2022-08-01)

Immunohistochemical features of the granulation tissue structure in the primary and secondary apical periodontitis.
by: P. I. Gritsenko, et al.
Published: (2015-03-01)

Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding
by: Donatella Pia Spanò, et al.
Published: (2022-02-01)

The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges
by: Salvatore Costa, et al.
Published: (2022-07-01)

Dye-Mediated Photo-Oxidation Biomaterial Fixation: Analysis of Bioinductivity and Mechanical Properties of Bovine Pericardium for Use in Cardiac Surgery
by: Simranjit S. Pattar, et al.
Published: (2021-10-01)

ELECTRICAL INSTABILITY OF MYOCARDIUM IN INFARCTION PATIENTS AND ITS PROGNOSTIC SIGNIFICANCE
by: P. Yu. Galin, et al.
Published: (2016-08-01)

Prognostic value of matrix metalloproteinases and transforming growth factor – β in kidney cancer
by: A. I. Tarasenko, et al.
Published: (2022-06-01)

Quantitative Proteomics Reveals Changes Induced by TIMP-3 on Cell Membrane Composition and Novel Metalloprotease Substrates
by: Anna Paola Carreca, et al.
Published: (2021-02-01)

MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
by: Yu. Yu. Rakina, et al.
Published: (2017-09-01)

NETWORK APPROACH TO ANALYSIS OF QUANTITATIVE TRAIT LOCI FOR TUMOR NECROSIS FACTOR (TNFα-863, TNFα-308, TNFα-238), VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF-2578, VEGF+936) AND MATRIX METALLOPROTEINASE (ММР2-1306, ММР3-1171, ММР9-1569) GENES IN AGERELATED MACULAR DEGENERATION
by: A. V. Shevchenko, et al.
Published: (2017-10-01)

Mesenchymal Stem Cell-Derived Exosomes Improve the Microenvironment of Infarcted Myocardium Contributing to Angiogenesis and Anti-Inflammation
by: Xiaomei Teng, et al.
Published: (2015-12-01)

Expression of GR, COX2и MMP1 genes in peripheral blood leukocytes after intensive therapy of the patients with chronic obstructive lung disease
by: N. D. Yelshin, et al.
Published: (2015-03-01)

Determination of left ventricular ejection fraction and C-reactive protein by the state of ischemic myocardium – capabilities of ECG digitalization
by: V. K. Tashchuk, et al.
Published: (2023-12-01)

Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
by: Arleta Waszczykowska, et al.
Published: (2020-11-01)

Microarray Analysis for Transcriptomic Profiling of Myocardium in Patients with Fatal Myocardial Infarction
by: Vyacheslav Ryabov, et al.
Published: (2023-12-01)

ASSOCIATION OF COMBINED GENOTYPE OF POLYMORPHIC CYTOKINE GENES SITES, ENDOTHELIAL GROWTH FACTOR AND METALLOPROTEASES WITH MYOCARDIAL INFARCTION DEVELOPMENT IN MEN
by: V. I. Konenkov, et al.
Published: (2014-10-01)

VECTOR ELECTROCARDIOGRAPHY IN THE DIAGNOSTICS OF FOCAL CHANGES IN THE MYOCARDIUM
by: I. Ye. Belaya, et al.
Published: (2015-04-01)

Transcriptome Profile Reveals Differences between Remote and Ischemic Myocardium after Acute Myocardial Infarction in a Swine Model
by: María Pulido, et al.
Published: (2023-02-01)

Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor?
by: Nuccia Morici, et al.
Published: (2020-01-01)

INFLUENCE OF COMPLETENESS HEART REVASCULARIZATION ON A FUNCTIONAL CONDITION OF MYOCARDIUM AT ISCHEMIC CARDIOMYOPATHY
by: V. V. Chestukhin, et al.
Published: (2014-05-01)